Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C9H10ClNO2 |
| Molecular Weight | 199.634 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(CC1=CC=C(Cl)C=C1)C(O)=O
InChI
InChIKey=NIGWMJHCCYYCSF-UHFFFAOYSA-N
InChI=1S/C9H10ClNO2/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8H,5,11H2,(H,12,13)
| Molecular Formula | C9H10ClNO2 |
| Molecular Weight | 199.634 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Fenclonine, also known as p-chlorophenylalanine, is an inhibitor of tryptophan hydroxylase, the enzyme that plays a rate-limiting role in the biosynthesis of serotonin. Fenclonine was studied for the treatment of carcinoid syndrome, but the psychological side effects, prevented for the further development for this use.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice. | 2005-06 |
|
| The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature. | 2005-06 |
|
| Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort. | 2005-05 |
|
| Involvement of serotonin in the hypoglycemic response to 2 Hz electroacupuncture of zusanli acupoint (ST36) in rats. | 2005-04-29 |
|
| Serotonin refines the locomotor-related alternations in the in vitro neonatal rat spinal cord. | 2005-03 |
|
| Analysis of serotonin in brain microdialysates using capillary electrophoresis and native laser-induced fluorescence detection. | 2005-03 |
|
| A reassessment of the role of serotonergic system in the control of feeding behavior. | 2005-03 |
|
| Long-lasting effects of serotonin deficiency on differentiating peptidergic neurons in the rat suprachiasmatic nucleus. | 2005-02 |
|
| Serotonin modulates the suppressive effects of corticosterone on proliferating progenitor cells in the dentate gyrus of the hippocampus in the adult rat. | 2005-02 |
|
| Dissociating barrel development and lesion-induced plasticity in the mouse somatosensory cortex. | 2005-01-19 |
|
| GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent. | 2005-01 |
|
| Tetrandrine, a bisbenzylisoquinoline alkaloid from Chinese herb Radix, augmented the hypnotic effect of pentobarbital through serotonergic system. | 2004-12-15 |
|
| Serotonin and stress: protective or malevolent actions in the biobehavioral response to repeated trauma? | 2004-12 |
|
| 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. | 2004-12 |
|
| Serotonin involvement in the electroacupuncture- and moxibustion-induced gastric emptying in rats. | 2004-10-15 |
|
| Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine. | 2004-10-15 |
|
| Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. | 2004-10-15 |
|
| 5-HT-mediated inhibition of cardiovagal baroreceptor reflex response during defense reaction in the rat. | 2004-10 |
|
| Loss of flight and associated neuronal rhythmicity in inositol 1,4,5-trisphosphate receptor mutants of Drosophila. | 2004-09-08 |
|
| Effects of autacoid inhibitors and of an antagonist on malaria infection in mice. | 2004-08 |
|
| Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus. | 2004-07-26 |
|
| Immediate plasticity in the motor pathways after spinal cord hemisection: implications for transcranial magnetic motor-evoked potentials. | 2004-06 |
|
| NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: a mechanism for learning impairment. | 2004-05 |
|
| Brain serotonin depletion enhances the sodium appetite induced by sodium depletion or beta-adrenergic stimulation. | 2004-03 |
|
| Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. | 2004-03 |
|
| Serotonin regulates mammary gland development via an autocrine-paracrine loop. | 2004-02 |
|
| 5-HT1A and beta-adrenergic receptors regulate proliferation of rat blood lymphocytes. | 2004 |
|
| Serotonergic and dopaminergic influence of the duration of embryogenesis and intracapsular locomotion of Lymnaea stagnalis L. | 2004 |
|
| Endogenous 5-HT inhibits firing activity of hippocampal CA1 pyramidal neurons during conditioned fear stress-induced freezing behavior through stimulating 5-HT1A receptors. | 2004 |
|
| Decreased serotonin level during pregnancy alters morphological and functional characteristics of tonic nociceptive system in juvenile offspring of the rat. | 2003-11-13 |
|
| Serotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice. | 2003-10-17 |
|
| Elimination of serotonergic cells induces a marked increase in generation of dopaminergic neurons from mesencephalic precursors. | 2003-10 |
|
| Orienting and defensive behaviors elicited by superior colliculus stimulation in rats: effects of 5-HT depletion, uptake inhibition, and direct midbrain or frontal cortex application. | 2003-09-15 |
|
| The effects of serotonin on the differentiation of neurons producing vasoactive intestinal polypeptide in the suprachiasmatic nucleus of the rat. | 2003-09 |
|
| Effect of the inhibition of serotonin biosynthesis on the antinociception induced by nonsteroidal anti-inflammatory drugs. | 2003-08-30 |
|
| Prenatal serotonin depletion changes the behavioral response in the nociceptive formalin test in rats. | 2003-08-28 |
|
| Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent? | 2003-07 |
|
| Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats. | 2003-06 |
|
| Influence of serotonin on the development and migration of gonadotropin-releasing hormone neurones in rat foetuses. | 2003-06 |
|
| [Osmoregulating reactions following serotonin metabolism inhibition or activation]. | 2003-04 |
|
| Serotonin depletion enhances the intracerebroventricularly administered MK-801-induced plasma interleukin-6 levels in mice. | 2003-04 |
|
| Increases in avoidance responding produced by REM sleep deprivation or serotonin depletion are reversed by administration of 5-hydroxytryptophan. | 2003-03-18 |
|
| Serotonin depletion increases respiratory variability in freely moving rats: implications for panic disorder. | 2003-03 |
|
| Serotonin-GABA interactions in the modulation of mu- and kappa-opioid analgesia. | 2003-03 |
|
| Short-term effects of 3,4-methylenedioximethamphetamine on noradrenergic activity in locus coeruleus and hippocampus of the rat. | 2003-02-13 |
|
| 5-HT1 and 5-HT2 receptor activation reduces N-methyl-D-aspartate (NMDA)-stimulated LH secretion in prepubertal male and female rats. | 2003-01 |
|
| Depletion of endogenous serotonin synthesis with p-CPA attenuates upregulation of constitutive isoform of heme oxygenase-2 expression, edema formation and cell injury following a focal trauma to the rat spinal cord. | 2003 |
|
| Synaptic loss following depletion of noradrenaline and/or serotonin in the rat visual cortex: a quantitative electron microscopic study. | 2003 |
|
| Pharmacological blockage of serotonin biosynthesis and circadian changes in oxaliplatin toxicity in rats. | 2002-11 |
|
| The effects of DL-p-chlorophenylalanine and DL-alpha-methyl-p-tyrosine on the brain catecholamine, serotonin and free amino acid contents in rat. | 1975-12-31 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4257000
Unknown
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11450100
Curator's Comment: Pretreatment with p-Chlorophenylalanine (FENCLONINE) significantly attenuated breakdown of the BBB permeability, brain edema and the cerebral blood flowdisturbances.
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:49:10 GMT 2025
by
admin
on
Mon Mar 31 18:49:10 GMT 2025
|
| Record UNII |
R5J7E3L9SP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C471
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2382
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY | |||
|
FENCLONINE
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY | |||
|
100000081268
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY | |||
|
7424-00-2
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY | |||
|
C81112
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY | |||
|
DTXSID4045139
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY | |||
|
4652
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY | |||
|
D010134
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY | |||
|
231-051-9
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL1256351
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY | |||
|
SUB07551MIG
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY | |||
|
77370
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY | |||
|
R5J7E3L9SP
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY | |||
|
7747
Created by
admin on Mon Mar 31 18:49:10 GMT 2025 , Edited by admin on Mon Mar 31 18:49:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
In vivo it is a potent and irreversible inhibitor of TPH (and PAH) that increases phenylalanine levels and rapidly depletes serotonin from the nervous system
IRREVERSIBLE INHIBITOR
IC50
|
||
|
|
ENANTIOMER -> RACEMATE | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |